Company Overview and News
Cobalt miner news - BHP seeking to add cobalt sulphate from Nickel West operation. China Molybdenum net profit set to surge between 271.21% and 295.16%.
SIE PIO CLA PANRF BLT CCZ PAN HAV MCR KBGCF CTM AXE ECSIF IGO VIC BAR AOU HIG PCRCF PLM.RT SNNAF FQM MCRZF BXTMF MLX PSDNF POM AYR CDU RGARF CHK MCRZY FTMDF KAT RER BBL CSSQF BHPLF GMRSF CZN PGM GBLEF NZRIF AZS GLCNF DLE HBNRF MEI PIONF GAL CZI AMSLF BPLNF HMI POS AUZ RNX GME FQVLF AQR PTNUF FT BHPBF HNLMF ORR CDNMD 3993 UMICY CDNMF IIDDY AEOMF USCFF FTSSF KATFF BBBMF MLXEF OZMLF PLM BHP CNJ AZRMF HLPCF BPL BHP OZL ARV
White Cliff Minerals Ltd (ASX:WCN) will seek shareholder approval to consolidate its issued share structure on a 50:1 basis and will also seek to divest non-core assets.
GME Resources Ltd (ASX:GME) has completed the pre-feasibility study for its NiWest Nickel-Cobalt Project in Western Australia, confirming a technically and financially robust long-life operation.
White Cliff Minerals Ltd (ASX:WCN) has received another batch of assays from its 5,000-metre reverse circulation (RC) drill program at the Coronation Dam project in Western Australia.
White Cliff Minerals Ltd (ASX:WCN) has discovered a 550-metre wide zone of cobalt mineralisation at its Coronation Dam project, 90 kilometres from the Murrin Murrin Nickel Refinery in Western Australia.
Cobalt market news - Darton forecasts 40% growth in cobalt demand in 2018. Tony Southgate (ERG) says: "The cobalt boom is guaranteed for the next seven to 10 years."
SIE PIO CLA PANRF RIO CCZ PAN HAV MCR KBGCF CTM FCX AXE IGO VIC BAR AOU HIG PCRCF PLM.RT SNNAF FQM MCRZF BXTMF MLX PSDNF POM AYR SHERF CDU RGARF CHK MCRZY CLQ FTMDF KAT RIO RER CSSQF GMRSF CZN PGM GBLEF NZRIF RIO AZS GLCNF DLE HBNRF MEI PIONF CZI AMSLF BPLNF HMI POS AUZ RNX RTPPF GME RTNTF FQVLF AQR PTNUF FT HNLMF ORR CDNMD 3993 UMICY CDNMF IIDDY AEOMF USCFF FTSSF KATFF BBBMF MLXEF OZMLF PLM CNJ AZRMF HLPCF BPL BHP OZL ARV
White Cliff Minerals Ltd (ASX:WCN) has identified thick cobalt and nickel intervals while logging core from drilling at the Coronation Dam Cobalt-Nickel Project in Western Australia.
2018-07-03 seekingalpha - 2
This article was first published on Trend Investing on May 4; therefore all data is as of that date.
URA CLA CCZ SRHYY KBGCF CYDVF LMRMF PCRCF PLM.RT HNCKF SNNAF ZEYYF WML POR SQM AVLNF BXTMF AIS.H POM AYR KBBRF ABE FTMDF MNIKF GBLEF GLCNF TON NMKEF POS DNI MGXMF DJIFF GME CRECF AQR LMR NGPHF CDNMD LEMIF CDNMF GLK WWR AEOMF KATFF KNL NTTHF ECORF URI CNJ TSLA FCSMF HLPCF CUC AJM WSCRF GRXXF SIE TNTMF CXO SAV HAV LIACF MUM URLNF NI HIG URRE PFFOF TAKRF ABEPF PSDNF STLHF SYA GPHOF LLG APMFD WMLLF APMFF NSRC CYLYF NGZ RNX.WT GXY KAT PLU VNCKF AMLM CSSQF XTM AVL ALB FMS LACDF HBNRF CZI ZENYF AUZ RNX PLUUF RNKLF DMNKF NMX SYR GLKIF EMH OROCF MSMGD LAC MSMGF PLS FT CARCF FTI.WI FMC ZEN USCFF DJI SYAAF PDDTF PLM AVLIF CYP NSRCF MGPHF MCCBF LNZCF ORE AVZ
Indian state-owned firms mandated to acquire overseas lithium and cobalt assets - A rough deadline of March 2019.
SIE PIO CLA PANRF CCZ PAN HAV MCR KBGCF CTM AXE IGO VIC BAR AOU HIG PCRCF PLM.RT TAKRF SNNAF FQM MCRZF BXTMF MLX PSDNF POM AYR CDU RGARF CHK MCRZY FTMDF KAT RER CSSQF GMRSF CZN PGM GBLEF NZRIF AZS DLE HBNRF MEI PIONF BPLNF CZI AMSLF HMI POS AUZ RNX GME FQVLF AQR PTNUF PCRFY FT HNLMF ORR CDNMD CDNMF IIDDY AEOMF USCFF KATFF BBBMF MLXEF OZMLF PLM CNJ AZRMF TSLA HLPCF BPL BHP OZL ARV
2018-05-17 seekingalpha - 1
Six cobalt junior developers can each produce ~5,000 tonnes pa of cobalt by 2021/22. These companies each have the potential to be worth ~AUD 3b if cobalt prices remain strong.
CLA CCZ HAV GLCNF ECSIF CZI AMSLF BPLNF POS HIG AUZ RNX RNKLF GME AQR FT PSDNF AYR AEOMF KATFF RNX.WT FTMDF KAT CNJ BPL HLPCF CSSQF
White Cliff Minerals Ltd (ASX: WCN) has started reverse circulation drilling at its Coronation Dam cobalt project near Kookynie in Western Australia’s north-eastern Goldfields.
2018-04-25 seekingalpha - 1
Cobalt miner news - South Korea's LG Chem to set up battery material JVs with China's Zhejiang Huayou Cobalt.
SIE PIO PANRF CCZ PAN HAV MCR KBGCF FCX IGO VIC BAR AOU HIG PCRCF PLM.RT TAKRF SNNAF FQM MCRZF BXTMF MLX PSDNF POM AYR SHERF CDU RGARF CHK MCRZY FTMDF KAT RER CSSQF GMRSF CZN PGM GBLEF NZRIF AZS DLE HBNRF MEI PIONF CZI AMSLF BPLNF HMI POS AUZ RNX GME FQVLF AQR PTNUF FT HNLMF ORR CDNMD CDNMF IIDDY AEOMF USCFF KATFF MLXEF OZMLF PLM CNJ AZRMF HLPCF BPL BHP OZL ARV
2018-04-17 seekingalpha - 1
This article first appeared on Trend Investing on February 16, therefore all data is as of that date.
SIE PANRF NSRPF PAN HAV KBGCF MCR IGO VIC BAR AOU HIG PLM.RT TAKRF SNNAF FQM MCRZF MLX PSDNF POM CHK RNX.WT MCRZY FTMDF KAT AAUKF CSSQF CZN PGM GBLEF AZS HBNRF MEI CZI AMSLF BPLNF HMI POS AUZ RNX RNKLF GME FQVLF AQR PTNUF FT HNLMF NVO ORR AAL IIDDY AEOMF USCFF KATFF MLXEF OZMLF PLM CBLLF CNJ AZRMF BPL HLPCF BHP OZL NGLOY ARV
2018-03-25 seekingalpha - 1
Cobalt spot price news - Spot prices rise 18.7% in the past month as inventory falls. The cobalt spot price is now over USD 40/lb, and approaching USD 100,000/tonne.
SIE PIO PANRF HAV PAN KBGCF MCR FCX ECSIF IGO VIC BAR AOU HIG PLM.RT TAKRF UMICF SNNAF FQM LGI MCRZF BXTMF MLX PSDNF POM CDU RGARF CHK VLKAF MCRZY FTMDF KAT RER CSSQF GMRSF CZN PGM GBLEF NZRIF AZS GLCNF DLE HBNRF MEI PIONF CZI AMSLF HMI POS AUZ RNX GME AAPL FQVLF AQR MBL PTNUF FT HNLMF ORR CDNMD 3993 UMICY CDNMF IIDDY AEOMF USCFF KATFF MLXEF OZMLF PLM S CNJ AZRMF HLPCF BHP OZL ARV
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to ASX:GME / GME RESOURCES LIMITED on message board site Silicon Investor.